We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 20 results
  1. Characterization and Applications of Permeabilized Hepatocytes in Drug Discovery

    Hepatocytes are one of the most physiologically relevant in vitro liver systems for human translation of clearance and drug-drug interactions (DDI)....

    Sam Zhang, Christine C. Orozco, ... Li Di in The AAPS Journal
    Article 28 March 2024
  2. Skeletal Muscle Relaxants

    Skeletal muscle relaxants are used to achieve muscle relaxation during anesthesia and to treat conditions associated with muscle spasticity. These...
    Chapter 2021
  3. Drug Repurposing for Spinal Cord Injury: Progress Towards Therapeutic Intervention for Primary Factors and Secondary Complications

    Spinal cord injury (SCI) encompasses a plethora of complex mechanisms like the involvement of major cell death pathways, neurodegeneration of spinal...

    Lahanya Guha, Hemant Kumar in Pharmaceutical Medicine
    Article 12 September 2023
  4. Influence of CYP2D6 and CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy volunteers

    Purpose

    This is the first study that connects pharmacokinetics of tolperisone with genetic polymorphism of the enzymes involved in its metabolism in...

    M. Pawlowska, M. Bogiel, ... E. Sieradzki in European Journal of Clinical Pharmacology
    Article 09 May 2015
  5. Drug-target based cross-sectional analysis of olfactory drug effects

    Background

    Drug effects on the human sense of smell attract increasing interest, yet systematic evidence from controlled studies is sparse. The...

    Jörn Lötsch, Helena Daiker, ... Thomas Hummel in European Journal of Clinical Pharmacology
    Article 11 February 2015
  6. Muscle Relaxants

    Nikolai Bogduk in Encyclopedia of Pain
    Reference work entry 2013
  7. Modulation of oxidative stress as an anticancer strategy

    The regulation of oxidative stress is an important factor in both tumour development and responses to anticancer therapies. Many signalling pathways...

    Chiara Gorrini, Isaac S. Harris, Tak W. Mak in Nature Reviews Drug Discovery
    Article 29 November 2013
  8. Psychiatric symptoms of patients with primary mitochondrial DNA disorders

    Background

    The aim of our study was to assess psychiatric symptoms in patients with genetically proven primary mutation of the mitochondrial DNA.

    ...
    Gabriella Inczedy-Farkas, Viktoria Remenyi, ... Maria Judit Molnar in Behavioral and Brain Functions
    Article Open access 13 February 2012
  9. Genetic and proteomic approaches to identify cancer drug targets

    While target-based small-molecule discovery has taken centre-stage in the pharmaceutical industry, there are many cancer-promoting proteins not...

    G Roti, K Stegmaier in British Journal of Cancer
    Article Open access 13 December 2011
  10. Human pharmacokinetics of the muscle relaxant, eperisone hydrochloride by liquid chromatography–electrospray tandem mass spectrometry

    Eperisone hydrochloride (4′-ethyl-2-methyl-3-piperidinopropiophenone hydrochloride) is a muscle relaxant agent, widely used in the treatment of...

    Barbara Melilli, Cateno Piazza, ... Filippo Drago in European Journal of Drug Metabolism and Pharmacokinetics
    Article 30 March 2011
  11. Spastic Paraplegia, Hereditary

    Rebecca Schüle, Ludger Schöls in Encyclopedia of Molecular Mechanisms of Disease
    Reference work entry 2009
  12. Voltage-gated sodium channel blockers, 2001-2006: An overview

    Voltage-gated sodium channel blockers have long been used in the therapy of various central nervous system diseases, including epilepsy, chronic...

    Hedvig Bölcskei, István Tarnawa, Pál Kocsis in Medicinal Chemistry Research
    Article 18 December 2007
  13. The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine

    Rationale

    Clozapine is a unique antipsychotic, with efficacy against positive symptoms in treatment-resistant schizophrenic patients, and the ability...

    D. M. Weiner, H. Y. Meltzer, ... M. R. Brann in Psychopharmacology
    Article 16 July 2004
  14. Intestinal First-Pass Metabolism of Eperisone in the Rat

    Purpose . The purpose of this study was to clarify quantitatively the contribution of the intestine to the first-pass metabolism of eperisone in rats.

    Methods...

    Kiyoshi Mihara, Mina Matsumura, ... Hiroyasu Ogata in Pharmaceutical Research
    Article 01 August 2001
  15. T

    Ian K. M. Morton, Judith M. Hall in Concise Dictionary of Pharmacological Agents
    Chapter 1999
  16. New findings and symptomatic treatment for neurolathyrism, a motor neuron disease occurring in North West Bangladesh

    Neurolathyrism is a form of spastic paraparesis caused by the neuroexcitatory amino acid 3-N-oxalyl-L-2,3-diaminopropanoic acid (β-ODAP) present in...

    A Haque, M Hossain, ... J De Reuck in Spinal Cord
    Article 01 March 1994
  17. A study of adverse effects on the progeny after intoxication during pregnancy

    The pregnancy outcomes of 109 women who were intoxicated during pregnancy due to excessive amounts of drugs and other agents were studied. Seventy...

    Andrew Czeizel, István Szentesi, ... Péter Bucski in Archives of Toxicology
    Article 01 August 1988
  18. The uncertainty principal in vision

    During research into the relationship between the bandpass width of the spatial frequency characteristic (ΔF) and the size (D) of the receptive field...

    V. D. Glezer, V. E. Gauzel'man, V. V. Yakovlev in Neurophysiology
    Article 01 May 1986
  19. Antinociceptive action of tizanidine in mice and rats

    The antinociceptive action of tizanidine [5-chloro-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole], a centrally acting muscle relaxant, was...

    Tsutomu Kameyama, Toshitaka Nabeshima, ... Shigeyuki Yamada in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 01 August 1985
  20. Clinical Experience with Benzodiazepines in Psychosomatic Disorders

    Illness in general, of whatever type, is a reaction by the person to a variety of changing events both in the internal and external environments. In...
    D. Kelly in Benzodiazepines
    Chapter 1980
Did you find what you were looking for? Share feedback.